Related Experiment Videos
The EU AI Act: Implications for U.S. Health Care
Sebastian Porsdam Mann1,2, I Glenn Cohen3, Timo Minssen1,4,5
1Center for Advanced Studies in Bioscience Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Denmark.
Abstract:
AbstractThe European Union's Artificial Intelligence Act (AIA), which took effect on August 1, 2024, establishes the world's first comprehensive legal framework for AI, with significant implications for medical AI development and deployment worldwide. This article analyzes the AIA's key implications for physicians and medical innovators in the United States. We examine the Act's risk-based approach, extraterritorial reach, and potential to influence global medical AI policy. We outline the key provisions of the AIA for medical AI systems and discuss its measures to support innovation. As implementation begins, U.S. health care stakeholders must engage proactively with this new regulatory landscape to remain competitive and gain access to the EU market.
Related Concept Videos
Standards of Care II
Standards of Care I
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Drug Control Governance: Regulatory Bodies and Their Impact
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...